These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 7409723

  • 21. European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Forbes CD.
    Int J Clin Pract; 1997 Jun; 51(4):205-8. PubMed ID: 9287258
    [Abstract] [Full Text] [Related]

  • 22. [Evaluation of the results of using aspirin in preventing recurrence of myocardial infarct].
    Halawa B, Mazurek W.
    Wiad Lek; 1981 Oct 01; 34(19):1621-6. PubMed ID: 7039141
    [No Abstract] [Full Text] [Related]

  • 23. [Pro and con: Anticoagulation or thrombocyte function inhibitors in the prophylaxis of myocardial infarct? Arguments in favor of thrombocyte function inhibitors].
    Breddin K.
    Internist (Berl); 1980 Jul 01; 21(7):394-6. PubMed ID: 7007279
    [No Abstract] [Full Text] [Related]

  • 24. Is acetylsalicylic acid plus dipyridamole superior to ASA alone for secondary prevention of stroke?
    Dalton B, Papoushek C, Evans MF.
    Can Fam Physician; 2001 Nov 01; 47():2235-9. PubMed ID: 11768921
    [No Abstract] [Full Text] [Related]

  • 25. [Effect of persantin on selected platelet functions in myocardial infarct].
    Markiewicz M, Kowalewski J, Florkiewicz H, Pluta A, Koziara Z, Szponar M, Dmosyńska A.
    Pol Tyg Lek; 1980 Sep 01; 35(35):1343-5. PubMed ID: 7433215
    [No Abstract] [Full Text] [Related]

  • 26. [Use of acetylsalicylic acid in the prevention of re-occlusion following revascularization interventions. Results of a double-blind long term study].
    Ehresmann U, Alemany J, Loew D.
    Med Welt; 1977 Jul 01; 28(26):1157-62. PubMed ID: 886967
    [No Abstract] [Full Text] [Related]

  • 27. [Clinical and electrocardiographical observations on the evolution of myocardial infarct treated with a derivative of pyrimido-pyrimidine (Persantin) in intravenous infusion].
    Martinetti L, Balzano I.
    Minerva Med; 1966 Aug 11; 57(63):2699-710. PubMed ID: 5911867
    [No Abstract] [Full Text] [Related]

  • 28. [Observations on the treatment of myocardial infarct with 2-6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-5,4-d)-pyrimidine (Persantin) in slow venous perfusion].
    Marangoni R, Brera V, Ferrari A.
    Minerva Cardioangiol; 1966 Jun 11; 14(6):373-9. PubMed ID: 5917541
    [No Abstract] [Full Text] [Related]

  • 29. [Combination of acetylsalicylic acid with dipyridamole is better than acetylsalicylic acid monotherapy].
    Schindler B.
    Med Monatsschr Pharm; 2006 Nov 11; 29(11):421-3. PubMed ID: 17131692
    [No Abstract] [Full Text] [Related]

  • 30. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb 11; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 31. [Low-dose ASA and infarct prophylaxis. Acetylsalicylic acid (ASA): low doses with high efficiency].
    Internist (Berl); 1995 Jan 11; 36(1 Suppl Low-dose-a):1-4. PubMed ID: 9431355
    [No Abstract] [Full Text] [Related]

  • 32. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J.
    J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153
    [Abstract] [Full Text] [Related]

  • 33. [Platelet aggregation inhibitor in general practice. Every 3rd infarct prevented--reinfarction rate cut in half].
    Fliri M.
    MMW Fortschr Med; 2002 Aug 22; 144(33-34):38-41. PubMed ID: 12380142
    [Abstract] [Full Text] [Related]

  • 34. Aspirin for the primary prevention of myocardial infarction.
    Relman AS.
    N Engl J Med; 1988 Jan 28; 318(4):245-6. PubMed ID: 3275897
    [No Abstract] [Full Text] [Related]

  • 35. [Anti-adhesion and anti-coagulant substances in thrombosis therapy. Acetylsalicylic acid and Persantin in the spotlight].
    Stormorken H.
    Tidsskr Nor Laegeforen; 1971 Feb 28; 91(6):449-50. PubMed ID: 5546533
    [No Abstract] [Full Text] [Related]

  • 36. ESPRIT study design and outcomes--a critical appraisal.
    Einhäupl K.
    Curr Med Res Opin; 2007 Feb 28; 23(2):271-3. PubMed ID: 17288680
    [Abstract] [Full Text] [Related]

  • 37. [Results of prevention of second myocardial infarct with syncumar or aspirin].
    Kraska T, Malanowicz W, Skarzyńska M, Tymińska K.
    Kardiol Pol; 1981 Feb 28; 24(9):593-7. PubMed ID: 7029110
    [No Abstract] [Full Text] [Related]

  • 38. [Prevention of embolism due to chronic auricular fibrillation with persantin (dipyridamole) combined with aspirin].
    Han ZX, Ma GY, Ma CM.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr 28; 19(4):250. PubMed ID: 17448289
    [No Abstract] [Full Text] [Related]

  • 39. [Long-term therapy with clopidogrel in combination with ASA significantly reduces risk of death, myocardial infarct or stroke].
    Minerva Med; 2003 Apr 28; 94(2):XIII-IV. PubMed ID: 12916522
    [No Abstract] [Full Text] [Related]

  • 40. [Dipyridamole therapy in acute myocardial infarct].
    Avdiushko BR.
    Vrach Delo; 1977 Jan 28; (1):38-43. PubMed ID: 841989
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.